CHPF2 Antikörper (N-Term)
Kurzübersicht für CHPF2 Antikörper (N-Term) (ABIN631398)
Target
Alle CHPF2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- CSGLCA-T antibody was raised against the N terminal Of Csglca-T
-
Aufreinigung
- Affinity purified
-
Immunogen
- CSGLCA-T antibody was raised using the N terminal Of Csglca-T corresponding to a region with amino acids SLLRVSWIQGEGEDPCVEAVGERGGPQNPDSRARLDQSDEDFKPRIVPYY
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CSGLCA-T Blocking Peptide, (ABIN5613016), is also available for use as a blocking control in assays to test for specificity of this CSGLCA-T antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CSGLCA-T antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CHPF2 (Chondroitin Polymerizing Factor 2 (CHPF2))
-
Andere Bezeichnung
- CSGLCA-T
-
Hintergrund
- CSGlcA-T belongs to the chondroitin N-acetylgalactosaminyltransferase family. It transfers glucuronic acid (GlcUA) from UDP-GlcUA to N-acetylgalactosamine residues on the non-reducing end of the elongating chondroitin polymer. CSGlcA-T has no N-acetylgalactosaminyltransferase activity.
-
Molekulargewicht
- 18 kDa (MW of target protein)
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-